Harvard Bioscience Inc

NASDAQ:HBIOUnited States

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.

Contact Information

Headquarters

84 OCTOBER HILL RDHOLLISTON, MA, United States 01746

Phone

508-893-8999

Fax

508-429-5732

Executives

Chairman of the Board, President, Chief Executive Officer

James Green

Chief Financial Officer, Treasurer

Jennifer Cote

Lead Independent Director

Bertrand Loy

Independent Director

Katherine Eade

Independent Director

Alan Edrick